MarketFriction

Farmax India Ltd

NSE FARMAXIND · Household Products
₹0.05 +0.00%
NSE close2018-07-02
Market cap₹2.67 Cr.
No trades in 30 days

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018
Sales4.825.804.192.852.321.860.110.100.090.000.000.00
Expenses7.007.018.833.144.812.190.600.010.110.000.030.03
Operating Profit-2.18-1.21-4.64-0.29-2.49-0.33-0.490.09-0.020.00-0.03-0.03
OPM %-45.23%-20.86%-110.74%-10.18%-107.33%-17.74%-445.45%90.00%-22.22%
Other Income0.080.060.000.090.040.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.410.410.420.360.320.330.320.340.320.320.270.27
Profit before tax-2.51-1.56-5.06-0.56-2.77-0.66-0.81-0.25-0.34-0.32-0.30-0.30
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit-2.51-1.57-5.06-0.56-2.77-0.66-0.81-0.25-0.35-0.32-0.30-0.30
EPS in Rs-0.05-0.03-0.09-0.01-0.05-0.01-0.02-0.00-0.01-0.01-0.01-0.01
Mar 2006Mar 2007Aug 2008 17mMar 2009 7mMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016TTM
Sales5.026.0616.8219.7363.4177.2591.4347.4817.3220.9815.690.09
Expenses4.285.2714.6117.6854.9669.8286.0464.5818.3422.5824.150.17
Operating Profit0.740.792.212.058.457.435.39-17.10-1.02-1.60-8.46-0.08
OPM %14.74%13.04%13.14%10.39%13.33%9.62%5.90%-36.02%-5.89%-7.63%-53.92%-88.89%
Other Income0.000.000.000.00-1.131.261.75-102.220.381.780.290.00
Interest0.010.010.340.602.433.734.824.736.180.060.010.00
Depreciation0.360.361.370.781.672.454.762.542.022.221.601.18
Profit before tax0.370.420.500.673.222.51-2.44-126.59-8.84-2.10-9.78-1.26
Tax %37.84%38.10%36.00%37.31%24.22%14.34%-24.59%0.57%0.00%0.00%0.00%
Net Profit0.230.260.320.422.442.15-1.84-127.32-8.84-2.10-9.78-1.27
EPS in Rs0.030.040.08-0.07-3.12-0.22-0.04-0.18-0.04
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth12%-27%-31%-98%
Compounded Profit Growth%%17%72%
Stock Price CAGR-7%%%%
Return on Equity%%%%
Mar 2006Mar 2007Aug 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Equity Capital3.223.2211.0011.0012.6025.8325.8340.8340.8353.4253.42
Reserves0.550.8113.5814.0018.84316.1775.03-45.69-54.53-52.61-62.39
Borrowings0.000.009.0111.1816.1337.2030.0735.3841.4941.0241.00
Other Liabilities0.570.594.292.492.347.993.181.973.152.921.83
Total Liabilities4.344.6237.8838.6749.91387.19134.1132.4930.9444.7533.86
Fixed Assets1.220.8623.2023.1728.3430.9026.2923.9822.0520.0718.37
CWIP0.000.000.002.430.000.000.000.000.000.000.00
Investments1.111.151.151.150.00253.340.340.000.000.000.00
Other Assets2.012.6113.5311.9221.57102.95107.488.518.8924.6815.49
Total Assets4.344.6237.8838.6749.91387.19134.1132.4930.9444.7533.86
Mar 2006Mar 2007Aug 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Cash from Operating Activity-3.95-2.85-19.95-0.46-17.43-0.41
Cash from Investing Activity-325.821.26-3.780.421.561.22
Cash from Financing Activity330.231.5823.79-0.0316.09-4.06
Net Cash Flow0.46-0.010.06-0.070.22-3.25
Free Cash Flow-8.96-2.92-20.10-0.46-17.620.51
CFO/OP-57%-53%117%45%1,089%5%
Mar 2006Mar 2007Aug 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Debtor Days66.8969.27173.3983.2558.0873.2467.591.233.58120.56144.00
Inventory Days78.5435.9369.8569.6317.1876.65160.3132.33
Days Payable36.055.3310.663.942.1936.0445.1023.00
Cash Conversion Cycle66.8969.27173.39125.7488.68132.43133.2816.2344.19235.77153.33
Working Capital Days95.98110.22194.22166.87108.04122.66131.148.238.43280.62188.43
ROCE %11.03%4.47%16.24%2.92%0.93%-23.87%-9.12%-5.86%-26.46%
Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017
Promoters37.89%37.89%37.89%30.98%30.98%30.98%30.98%
FIIs0.84%0.84%0.84%0.00%0.00%0.00%0.00%
DIIs0.00%0.00%0.00%0.84%0.84%0.84%0.84%
Public61.28%61.28%61.28%68.19%68.19%68.19%68.19%
No. of Shareholders13,45713,57113,57113,57113,57013,57013,570

Fundamentals

Market Cap₹ 2.67 Cr.
Current Price₹ 0.05
Book Value₹ 0.42
ROCE-26.5 %
ROE%
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)-98%
Compounded Profit Growth (TTM)72%
Standalone figures.
Valuation
Market capRs 3 Cr
Enterprise valueRs 43 Cr
Price to book-0.30x
Price to sales0.17x
EV / sales2.77x
Earnings yield-47.55%
P/B, 3-year average11.41x
P/B, 5-year average6.17x
Profitability
Operating margin (excl. other income)-53.92%
Operating margin (incl. other income)-52.07%
EBITDA margin-0.45%
Pre-tax margin-8.03%
Net profit margin-8.09%
ROE239.71%
ROCE-26.46%
ROA-24.88%
ROE, 3-year average122.52%
ROCE, 3-year average-13.81%
ROA, 3-year average-19.43%
ROE, 5-year average20.29%
ROCE, 5-year average-38.29%
ROA, 5-year average-42.37%
ROIC (approx.)-3.93%
Other income / net worth-3.23%
Growth
Sales growth (latest year)-25.21%
Sales CAGR, 3 years-30.86%
Sales CAGR, 5 years-27.30%
Per share
EPS (TTM)Rs -0.02
EPS (latest year)Rs -0.18
EPS (latest quarter)Rs -0.01
EPS, 3-year averageRs -0.15
EPS, 5-year averageRs -0.73
Book value per shareRs -0.17
Sales per shareRs 0.29
Cash flow per shareRs -0.01
Free cash flow per shareRs 0.01
Efficiency
Asset turnover0.46x
Fixed asset turnover0.85x
Inventory turnover11.71x
Inventory days31 days
Debtor days144 days
Debtors turnover2.53x
Creditor days23 days
Cash conversion cycle153 days
Working capital days188 days
Leverage
Total debtRs 41 Cr
Cash and bankRs 0 Cr
Net debtRs 41 Cr
Debt to equity-4.57x
Interest coverage-125.00x
Owners' fund to total sources-26.49%
Debt to assets121.09%
Cash flow
Cash from Operating Activity (latest year)Rs -0 Cr
Cash from Investing Activity (latest year)Rs 1 Cr
Cash from Financing Activity (latest year)Rs -4 Cr
Net Cash Flow (latest year)Rs -3 Cr
Free cash flow (latest year)Rs 1 Cr
FCFE (approx.: FCF + change in debt)Rs 0 Cr
Statement figures
Net sales (TTM)Rs 16 Cr
Net sales (latest year)Rs 16 Cr
Operating profit excl. other income (latest year)Rs -8 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -1 Cr
Net profit (TTM)Rs -1 Cr
Net profit (latest year)Rs -10 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 23 Cr
Total expenditure (latest year)Rs 24 Cr
Total income (latest year)Rs 16 Cr
Share capitalRs 53 Cr
ReservesRs -62 Cr
Shareholders' fundsRs -9 Cr
Total assetsRs 34 Cr
Net blockRs 18 Cr
ReceivablesRs 6 Cr
InventoryRs 2 Cr
Other liabilitiesRs 2 Cr
Shares outstanding (crore)53.42
Ownership
Promoter holding30.98% (-6.91 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
PeriodFARMAXINDNifty 50Difference
1 week+0.0%-2.8% +2.8 pts
1 month-50.0%-6.8% -43.2 pts
3 months-66.7%-7.6% -59.0 pts
6 months-50.0%+0.4% -50.4 pts
1 year-66.7%-9.9% -56.7 pts
2 years-90.0%-13.6% -76.4 pts
3 years-87.5%+14.2% -101.7 pts
5 years-85.7%+27.9% -113.6 pts

Red flags

F-score 2 of 8
seriousNegative equity Shareholders' equity is negative
explainShare dilution Share count up 0% in a year, 31% in three
lookRepeated losses Net loss in each of the last two years
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Mar 2018
Sales ₹0 Cr -100.0% vs Mar 2017. Net loss ₹0 Cr.

Activity

Compare
No bulk or block deals on record.
Ex-dateActionFactor
2016-09-22 Annual General Meeting (Book Closure Start Date Revised)
2015-09-23 Annual General Meeting
2014-09-18Annual General Meeting
2013-07-18Annual General Meeting
2012-09-20Annual General Meeting
2011-10-24Annual General Meeting
2010-12-03Annual General Meeting
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Farmax India Ltd?

Farmax India Ltd (FARMAXIND) has a market capitalisation of Rs 2.67 Cr. at the 2018-07-02 close.

What were Farmax India Ltd's latest quarterly results?

In the Mar 2018 quarter, Farmax India Ltd sales was Rs 0 Cr (-100.0% vs Mar 2017) with a net loss of Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03